MAIA
MAIA Biotechnology Inc.
NYSE MKT: MAIA · HEALTHCARE · BIOTECHNOLOGY
$1.30
+4.00% today
Updated 2026-04-29
Market cap
$75.23M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.70
Dividend yield
—
52W range
$1 – $3
Volume
0.9M
MAIA Biotechnology Inc. (MAIA) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — |
| Gross margin | — | — | — | — | — | — | — |
| R&D | $1.91M | $1.41M | $3.45M | $8.93M | $11.11M | $10.01M | $14.55B |
| SG&A | $5.01M | $5.56M | $4.29M | $6.14M | $9.07M | $6.95M | $9.72B |
| Operating income | $-6.92M | $-6.98M | $-7.79M | $-16.18M | $-20.18M | $-16.96M | $-24.27M |
| Operating margin | — | — | — | — | — | — | — |
| EBITDA | $242.00 | $-6.97M | $-11.75M | $-15.76M | $-19.77M | $-23.25M | $-24.27M |
| EBITDA margin | — | — | — | — | — | — | — |
| EBIT | $-6.92M | $-13.95M | $-15.53M | $-16.18M | $-20.18M | $-23.25M | — |
| Interest expense | $0.00 | $31547.00 | $827539.00 | $6967.00 | $6863.00 | $57.00 | $0.00 |
| Income tax | $-435000.00 | $-291000.00 | $707530.00 | $36689.00 | $-176719.00 | $-79954.00 | — |
| Effective tax rate | 6.3% | 4.2% | -6.0% | -0.2% | 0.9% | 0.3% | 0.0% |
| Net income | $-6.49M | $-6.64M | $-12.50M | $-15.77M | $-19.77M | $-23.25M | $-22.40M |
| Net income growth (YoY) | — | -2.2% | -88.4% | -26.1% | -25.4% | -17.6% | +3.7% |
| Profit margin | — | — | — | — | — | — | — |